Published in Radiology on April 04, 2014
Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay. J Magn Reson Imaging (2015) 0.96
Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma. Sci Rep (2015) 0.85
Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response. Transl Oncol (2015) 0.83
Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy. J Magn Reson Imaging (2016) 0.82
How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis? Acad Radiol (2016) 0.79
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays. Radiology (2016) 0.78
Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma. J Magn Reson Imaging (2016) 0.78
Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage. Cancer (2015) 0.77
Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer. Breast Cancer Res (2016) 0.77
Imaging genomics in cancer research: limitations and promises. Br J Radiol (2016) 0.77
A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores. Sci Rep (2016) 0.76
DCE-MRI, DW-MRI, and MRS in Cancer: Challenges and Advantages of Implementing Qualitative and Quantitative Multi-parametric Imaging in the Clinic. Top Magn Reson Imaging (2016) 0.75
Predictive radiogenomics modeling of EGFR mutation status in lung cancer. Sci Rep (2017) 0.75
Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set. NPJ Breast Cancer (2016) 0.75
Relating Doses of Contrast Agent Administered to TIC and Semi-Quantitative Parameters on DCE-MRI: Based on a Murine Breast Tumor Model. PLoS One (2016) 0.75
Integration and comparison of different genomic data for outcome prediction in cancer. BioData Min (2015) 0.75
Association between Ultrasound Features and the 21-Gene Recurrence Score Assays in Patients with Oestrogen Receptor-Positive, HER2-Negative, Invasive Breast Cancer. PLoS One (2016) 0.75
Multiple-response regression analysis links magnetic resonance imaging features to de-regulated protein expression and pathway activity in lower grade glioma. Oncoscience (2017) 0.75
Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation. J Magn Reson Imaging (2017) 0.75
Associations between gene expression profiles of invasive breast cancer and Breast Imaging Reporting and Data System MRI lexicon. Ann Surg Treat Res (2017) 0.75
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol (2009) 22.22
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol (2006) 20.28
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol (2006) 16.25
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res (2010) 10.90
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol (2009) 9.39
Tumor heterogeneity: causes and consequences. Biochim Biophys Acta (2009) 5.90
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. J Clin Oncol (2010) 4.75
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A (2008) 4.14
Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet (2011) 3.60
Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol (2007) 3.17
Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. Radiology (2012) 2.98
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol (2010) 2.23
Computerized interpretation of breast MRI: investigation of enhancement-variance dynamics. Med Phys (2004) 2.14
Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI. Med Phys (2006) 1.94
Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers. Radiology (2010) 1.60
Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement. J Natl Cancer Inst (2011) 1.45
Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma. J Vasc Interv Radiol (2007) 1.42
DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6. Br J Cancer (2011) 1.40
Prognostic and predictive factors revisited. Breast (2005) 1.39
Analyzing microarray data using cluster analysis. Pharmacogenomics (2003) 1.37
Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol (2003) 1.32
Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology (2008) 1.26
Automatic ultrasound segmentation and morphology based diagnosis of solid breast tumors. Breast Cancer Res Treat (2005) 1.23
Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology (2000) 1.22
MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol (2001) 1.22
Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. Radiology (2006) 1.18
Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy. Eur J Radiol (2008) 1.15
Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer. Clin Cancer Res (2010) 1.13
Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity. Int J Oncol (2006) 1.09
Heterogeneity of breast cancer: etiology and clinical relevance. Clin Transl Oncol (2011) 1.05
Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. Radiology (2011) 0.97
Mammography and ultrasound features of triple-negative breast cancer. Breast Cancer (2010) 0.96
MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy. Magn Reson Imaging Clin N Am (2006) 0.95
MRI in breast cancer therapy monitoring. NMR Biomed (2011) 0.95
Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy. J Oncol (2010) 0.93
Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation. Radiology (2013) 0.92
Advances in molecular imaging for breast cancer detection and characterization. Breast Cancer Res (2012) 0.89
Interpretation of breast MRI: correlation of kinetic and morphological parameters with pathological findings. Magn Reson Med Sci (2004) 0.88
Magnetic resonance imaging of breast lesions--a pathologic correlation. Breast Cancer Res Treat (2006) 0.86
The basics and implementation of digital mammography. Radiol Clin North Am (2010) 0.83
Correlation between numeric gadolinium-enhanced dynamic MRI ratios and prognostic factors and histologic type of breast carcinoma. AJR Am J Roentgenol (2006) 0.80
Dynamic contrast-enhanced magnetic resonance imaging and invasive breast cancer: primary lesion kinetics correlated with axillary lymph node extracapsular extension. J Magn Reson Imaging (2011) 0.78
Role of magnetic resonance imaging in evaluating the extent of disease. Magn Reson Imaging Clin N Am (2010) 0.77
BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res (2002) 8.55
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657. J Clin Oncol (2012) 2.85
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res Treat (2011) 2.73
caTIES: a grid based system for coding and retrieval of surgical pathology reports and tissue specimens in support of translational research. J Am Med Inform Assoc (2010) 2.62
Expectation-maximization-driven geodesic active contour with overlap resolution (EMaGACOR): application to lymphocyte segmentation on breast cancer histopathology. IEEE Trans Biomed Eng (2010) 2.52
A boosted Bayesian multiresolution classifier for prostate cancer detection from digitized needle biopsies. IEEE Trans Biomed Eng (2010) 2.41
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res (2007) 2.25
Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer. Hum Pathol (2013) 2.06
Assessing the significance of conserved genomic aberrations using high resolution genomic microarrays. PLoS Genet (2007) 1.95
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl (2004) 1.95
Digital imaging in pathology: whole-slide imaging and beyond. Annu Rev Pathol (2012) 1.89
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. J Clin Oncol (2003) 1.88
"Identifying the hospitalised patient in crisis"--a consensus conference on the afferent limb of rapid response systems. Resuscitation (2010) 1.78
Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene (2005) 1.78
Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl (2006) 1.72
Autofluorescence and diffuse reflectance spectroscopy of oral epithelial tissue using a depth-sensitive fiber-optic probe. Appl Opt (2008) 1.68
Registering histologic and MR images of prostate for image-based cancer detection. Acad Radiol (2007) 1.58
A boosting cascade for automated detection of prostate cancer from digitized histology. Med Image Comput Comput Assist Interv (2006) 1.57
Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor. Cancer Biol Ther (2009) 1.52
Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities. Radiology (2011) 1.48
Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. Radiology (2009) 1.48
Outcomes following fibroid expulsion after uterine artery embolization. J Vasc Interv Radiol (2011) 1.43
MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues. Int J Clin Exp Pathol (2009) 1.38
Outcome of MRI-guided breast biopsy. AJR Am J Roentgenol (2008) 1.33
Transoral robotic surgery and human papillomavirus status: Oncologic results. Head Neck (2010) 1.33
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest (2014) 1.33
The Cancer Biomedical Informatics Grid (caBIG<sup>TM</sup>). Conf Proc IEEE Eng Med Biol Soc (2005) 1.33
MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience. Radiology (2005) 1.32
Estimation of breast percent density in raw and processed full field digital mammography images via adaptive fuzzy c-means clustering and support vector machine segmentation. Med Phys (2012) 1.29
Determining histology-MRI slice correspondences for defining MRI-based disease signatures of prostate cancer. Comput Med Imaging Graph (2011) 1.28
An overview of marine biodiversity in United States waters. PLoS One (2010) 1.27
Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes (2003) 1.27
An active learning based classification strategy for the minority class problem: application to histopathology annotation. BMC Bioinformatics (2011) 1.20
Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis. Hum Pathol (2008) 1.19
HistoStitcher(©): an interactive program for accurate and rapid reconstruction of digitized whole histological sections from tissue fragments. Comput Med Imaging Graph (2011) 1.18
Breast percent density: estimation on digital mammograms and central tomosynthesis projections. Radiology (2009) 1.17
Melanoma seeding of an EUS-guided fine needle track. Gastrointest Endosc (2004) 1.17
The incidence of concurrent osteitis in patients with chronic rhinosinusitis: a clinicopathological study. Am J Rhinol (2006) 1.14
Integrated diagnostics: a conceptual framework with examples. Clin Chem Lab Med (2010) 1.14
Calcifications in the breast and digital breast tomosynthesis. Breast J (2011) 1.12
Phase I trial of combretastatin a-4 phosphate with carboplatin. Clin Cancer Res (2005) 1.12
Detection of THCA in oral fluid by GC-MS-MS. J Anal Toxicol (2006) 1.12
Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy. AJR Am J Roentgenol (2015) 1.12
Challenges and opportunities for reinvigorating the physician-scientist pipeline. J Clin Invest (2015) 1.11
Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Ann Surg Oncol (2013) 1.10
Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women. Int J Cancer (2006) 1.09
Multimodality screening of high-risk women: a prospective cohort study. J Clin Oncol (2009) 1.09
Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope (2006) 1.08
Application of immunohistochemistry to breast lesions. Arch Pathol Lab Med (2008) 1.06
Simultaneous assessment of gastric accommodation and emptying: studies with liquid and solid meals. J Nucl Med (2004) 1.04
Automated chest wall line detection for whole-breast segmentation in sagittal breast MR images. Med Phys (2013) 1.04
Graph embedding to improve supervised classification and novel class detection: application to prostate cancer. Med Image Comput Comput Assist Interv (2005) 1.03
Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis. Cancer Biol Ther (2005) 1.03
A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS). Med Phys (2009) 1.00
Automated fibroglandular tissue segmentation and volumetric density estimation in breast MRI using an atlas-aided fuzzy C-means method. Med Phys (2013) 0.99
MR imaging and MR spectroscopy in prostate cancer management. Radiol Clin North Am (2006) 0.98
Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Int J Cancer (2004) 0.96
H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer. Dig Dis Sci (2012) 0.96
CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth. Cancer Res (2003) 0.96
Detecting prostatic adenocarcinoma from digitized histology using a multi-scale hierarchical classification approach. Conf Proc IEEE Eng Med Biol Soc (2006) 0.96
Reader variability in breast density estimation from full-field digital mammograms: the effect of image postprocessing on relative and absolute measures. Acad Radiol (2013) 0.95
Multi-field-of-view strategy for image-based outcome prediction of multi-parametric estrogen receptor-positive breast cancer histopathology: Comparison to Oncotype DX. J Pathol Inform (2012) 0.95
Identification and optimization of anthranilic sulfonamides as novel, selective cholecystokinin-2 receptor antagonists. J Med Chem (2006) 0.95
Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma. Cancer (2011) 0.94
Registering histological and MR images of prostate for image-based cancer detection. Med Image Comput Comput Assist Interv (2006) 0.94
Ratiometric analysis in hyperpolarized NMR (I): test of the two-site exchange model and the quantification of reaction rate constants. NMR Biomed (2013) 0.93
Multi-field-of-view framework for distinguishing tumor grade in ER+ breast cancer from entire histopathology slides. IEEE Trans Biomed Eng (2013) 0.93
Breast MR imaging: current indications and advanced imaging techniques. Radiol Clin North Am (2010) 0.92
National Mesothelioma Virtual Bank: a standard based biospecimen and clinical data resource to enhance translational research. BMC Cancer (2008) 0.92
Cyclophosphamide treatment modifies tumor oxygenation and glycolytic rates of RIF-1 tumors: 13C magnetic resonance spectroscopy, Eppendorf electrode, and redox scanning. Cancer Res (2003) 0.92
Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome. Anticancer Res (2010) 0.92
A magnetic resonance spectroscopy driven initialization scheme for active shape model based prostate segmentation. Med Image Anal (2010) 0.92
Predictors of thyroid gland invasion in glottic squamous cell carcinoma. Laryngoscope (2005) 0.91
Spatially weighted mutual information (SWMI) for registration of digitally reconstructed ex vivo whole mount histology and in vivo prostate MRI. Conf Proc IEEE Eng Med Biol Soc (2011) 0.91
Applying spatial distribution analysis techniques to classification of 3D medical images. Artif Intell Med (2005) 0.91
A representation and classification scheme for tree-like structures in medical images: analyzing the branching pattern of ductal trees in X-ray galactograms. IEEE Trans Med Imaging (2008) 0.90
Spectral embedding based probabilistic boosting tree (ScEPTre): classifying high dimensional heterogeneous biomedical data. Med Image Comput Comput Assist Interv (2009) 0.90
Bronchoscopy and endobronchial disease in patients with human immunodeficiency virus infection. Indian J Chest Dis Allied Sci (2011) 0.89
Semi supervised multi kernel (SeSMiK) graph embedding: identifying aggressive prostate cancer via magnetic resonance imaging and spectroscopy. Med Image Comput Comput Assist Interv (2010) 0.89
Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional response. Cancer Lett (2007) 0.89
Mammographic parenchymal patterns as an imaging marker of endogenous hormonal exposure: a preliminary study in a high-risk population. Acad Radiol (2013) 0.88
Computer aided automatic detection of malignant lesions in diffuse optical mammography. Med Phys (2010) 0.88
Consensus-locally linear embedding (C-LLE): application to prostate cancer detection on magnetic resonance spectroscopy. Med Image Comput Comput Assist Interv (2008) 0.87
Red blood cell transfusion following burn. Burns (2011) 0.87
Immunohistochemical method identifies lymphovascular invasion in a majority of oral squamous cell carcinomas and discriminates between blood and lymphatic vessel invasion. J Histochem Cytochem (2008) 0.87
Metagenomic assay for identification of microbial pathogens in tumor tissues. MBio (2014) 0.86
Electrotherapy promotes healing and microcirculation of infrapopliteal ischemic wounds: a prospective pilot study. Adv Skin Wound Care (2004) 0.86
Breast reconstruction with a transverse rectus abdominis myocutaneous flap: spectrum of normal and abnormal MR imaging findings. Radiographics (2004) 0.86
Cell-based quantification of molecular biomarkers in histopathology specimens. Histopathology (2011) 0.86
A hierarchical unsupervised spectral clustering scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS). Med Image Comput Comput Assist Interv (2007) 0.86
Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients. Infect Agent Cancer (2010) 0.85
Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy. Biomed Opt Express (2012) 0.85
Detection of prostate cancer on histopathology using color fractals and Probabilistic Pairwise Markov models. Conf Proc IEEE Eng Med Biol Soc (2011) 0.84
Adaptive multi-cluster fuzzy C-means segmentation of breast parenchymal tissue in digital mammography. Med Image Comput Comput Assist Interv (2011) 0.84